Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rhabdomyosarcoma 5Wilms Tumor 4Sarcoma 4Hydatidiform Mole 2Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Malignant mesenchymal tumor 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Fibrosarcoma 1Choroid Plexus Neoplasms 1Choriocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1Blast Crisis 1Beckwith-Wiedemann Syndrome 1

Interventions

Radiotherapy, Conformal 2Ifosfamide 2Doxorubicin 2romidepsin 1indolepropanol phosphate 1etoposide phosphate 1Watchful Waiting 1Vincristine 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Polymerase Chain Reaction 1Observation 1Neoadjuvant Therapy 1Irinotecan 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Filgrastim 1Etoposide 1Dactinomycin 1Cyclophosphamide 1Blotting, Western 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Malignant mesenchymal tumor × Dactinomycin × Clear all
NCT00354744 2020-01-29

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Children's Oncology Group

Phase 3 Completed
109 enrolled 12 charts
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡